FDA
approval
· 2022-12-15
FDA Approved: LEVOCARNITINE — Supplemental Application (American Regent, Inc.)
Summary
FDA approved a supplemental application for levocarnitine by American Regent, Inc. under ANDA 075861, indicating a regulatory action on this generic product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LEVOCARNITINE (LEVOCARNITINE)